- Home
- YETI vs XENE Comparison
YETI vs XENE Comparison
Compare YETI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YETI
- XENE
- Stock Information
- Founded
- YETI 2006
- XENE 1996
- Country
- YETI United States
- XENE Canada
- Employees
- YETI N/A
- XENE N/A
- Industry
- YETI Recreational Games/Products/Toys
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- YETI Consumer Discretionary
- XENE Health Care
- Exchange
- YETI Nasdaq
- XENE Nasdaq
- Market Cap
- YETI 2.5B
- XENE 2.9B
- IPO Year
- YETI 2018
- XENE 2014
- Fundamental
- Price
- YETI $35.63
- XENE $37.51
- Analyst Decision
- YETI Buy
- XENE Strong Buy
- Analyst Count
- YETI 13
- XENE 11
- Target Price
- YETI $38.67
- XENE $52.73
- AVG Volume (30 Days)
- YETI 1.6M
- XENE 787.4K
- Earning Date
- YETI 11-06-2025
- XENE 08-11-2025
- Dividend Yield
- YETI N/A
- XENE N/A
- EPS Growth
- YETI N/A
- XENE N/A
- EPS
- YETI 2.10
- XENE N/A
- Revenue
- YETI $1,822,000,000.00
- XENE $7,500,000.00
- Revenue This Year
- YETI $3.23
- XENE N/A
- Revenue Next Year
- YETI $4.87
- XENE $256.34
- P/E Ratio
- YETI $16.99
- XENE N/A
- Revenue Growth
- YETI 3.63
- XENE N/A
- 52 Week Low
- YETI $26.61
- XENE $26.74
- 52 Week High
- YETI $45.25
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- YETI 52.85
- XENE 53.64
- Support Level
- YETI $34.35
- XENE $38.13
- Resistance Level
- YETI $36.98
- XENE $39.55
- Average True Range (ATR)
- YETI 1.01
- XENE 1.06
- MACD
- YETI 0.07
- XENE -0.27
- Stochastic Oscillator
- YETI 63.01
- XENE 17.52
About YETI YETI Holdings Inc.
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.